Meniscus Regeneration Using Gradient Biomaterials

Abstract

Meniscal injuries are a leading cause of knee dysfunction and osteoarthritis, particularly in active and aging populations. Traditional repair techniques and partial meniscectomy often fail to restore the meniscus's unique biomechanical properties, increasing the risk of joint degeneration. Gradient biomaterials represent a novel approach for meniscus regeneration, offering the potential to mimic the meniscus's complex zonal architecture and biomechanical heterogeneity. This review synthesizes current evidence on the design, clinical application, and regenerative outcomes of gradient biomaterials, focusing on their mechanisms of action, integration with native tissue, and future clinical translation.

Introduction

The meniscus plays a critical role in knee joint health, distributing load, absorbing shock, and contributing to joint stability. Meniscal injuries are prevalent in both young athletes and older individuals, with consequences that include pain, dysfunction, and a heightened risk of osteoarthritis. While repair and replacement strategies have evolved, none yet fully replicate the native meniscus's structure or function. Gradient biomaterials, engineered to recapitulate the meniscus's compositional and mechanical gradients, have emerged as a promising regenerative solution. This article provides a comprehensive review of the epidemiology, pathophysiology, clinical features, diagnostic strategies, current and emerging therapies, and guideline recommendations regarding meniscus regeneration using gradient biomaterials.

Epidemiology / Disease Burden

Meniscal tears account for a significant portion of knee injuries worldwide, with an estimated annual incidence of 60-70 per 100,000 persons. The burden is particularly high among individuals aged 15-35 years due to sports-related activities, and among the elderly due to degenerative changes. Meniscal injury is a well-established risk factor for early-onset osteoarthritis, contributing to substantial healthcare costs, reduced quality of life, and long-term disability. The high prevalence and recurrence rate of meniscal pathology underscore the need for durable and effective regenerative therapies.

Pathophysiology

The meniscus is a fibrocartilaginous structure with a distinct zonal organization: the outer (red-red) vascularized zone, the middle (red-white) zone, and the inner (white-white) avascular zone. This gradient in vascularity and extracellular matrix composition underlies the meniscus's unique biomechanical properties. Injury disrupts both the structural and functional integrity of the meniscus, particularly in the avascular inner region, where healing is limited. This impairment accelerates cartilage degeneration and joint instability, fueling a cycle of progressive osteoarthritis.

Risk Factors

Key risk factors for meniscal injury include high-impact sports, occupational activities involving squatting or kneeling, obesity, congenital meniscal anomalies, and advancing age. Degenerative tears are more common in older adults, while acute traumatic tears predominate in younger, active individuals. Previous knee injuries, ligamentous laxity, and limb malalignment further increase susceptibility to meniscal damage.

Clinical Features

Patients with meniscal injuries typically present with joint line pain, swelling, mechanical symptoms such as locking or catching, and restricted range of motion. On examination, joint effusion, tenderness along the joint line, and positive provocative tests (e.g., McMurray, Thessaly) may be observed. Chronic or untreated tears may manifest as recurrent effusions, persistent pain, and gradual functional decline, especially if meniscal tissue loss leads to altered joint mechanics.

Diagnosis

Diagnosis relies on a combination of clinical assessment and imaging. Magnetic resonance imaging (MRI) remains the gold standard, providing detailed visualization of meniscal morphology, tear pattern, and associated cartilage or ligamentous injuries. Arthroscopy, although invasive, allows for direct assessment and concurrent intervention. Emerging imaging modalities, including quantitative MRI and ultrashort echo time sequences, are being explored for enhanced evaluation of meniscal tissue quality and healing.

Treatment & Management

Conservative management may be appropriate for stable, non-obstructive tears, particularly in older adults or patients with low functional demands. Surgical options include meniscal repair, partial meniscectomy, and meniscal transplantation. However, these approaches are limited by poor healing in the inner avascular zone, risk of re-tear, and long-term joint deterioration. Regenerative strategies, including cell-based therapies, scaffolds, and biomaterials, aim to overcome these limitations by promoting tissue integration and functional restoration.

Recent Advances / Emerging Therapies

Gradient biomaterials are at the forefront of meniscus tissue engineering. These constructs are designed to mimic the native meniscus's zonal variation in composition and biomechanics, offering superior integration and regenerative potential. Multilayered scaffolds incorporating gradients of collagen, glycosaminoglycans, and synthetic polymers have demonstrated promising results in preclinical models, supporting native-like cell differentiation, matrix deposition, and mechanical function. Bioactive cues, such as growth factors and gene delivery, further enhance cell recruitment and tissue remodeling. Clinical translation remains in its infancy, with ongoing trials assessing safety, efficacy, and long-term outcomes.

Guideline Recommendations

Current orthopedic and sports medicine guidelines emphasize the preservation of meniscal tissue whenever feasible. Meniscal repair is preferred over meniscectomy, particularly in younger patients and those with repairable tears. The integration of biomaterial scaffolds is recommended in cases where native tissue preservation is not possible or where biological augmentation is needed to optimize healing. While gradient biomaterials are not yet standard of care, their use is supported in research settings and select clinical scenarios, with a strong emphasis on patient selection and multidisciplinary management.

Conclusion

Meniscus regeneration using gradient biomaterials represents a paradigm shift in the management of meniscal injuries. These advanced constructs offer the potential to restore the meniscus's complex architecture and biomechanical function, addressing limitations of traditional repair and replacement techniques. Ongoing research is needed to refine scaffold design, optimize biomolecule delivery, and confirm long-term clinical efficacy. As evidence accumulates, gradient biomaterials are poised to become integral to regenerative knee surgery, improving outcomes and preserving joint health for diverse patient populations.